Eden Research plc, listed on the AIM under the ticker EDEN, announced that its Annual Report and Accounts for the fifteen‑month period ended 31 March 2026 have been made available to shareholders. The report details the company's development of biopesticide and biocontrol technologies.
The company also issued a notice of its Annual General Meeting, which is scheduled for Tuesday, 29 September 2026, at 10:00 a.m. The meeting will take place at Cavendish's office, 1 Bartholomew Close, London EC1A 7BL. Shareholders can access the full report and AGM notice via the company's website, www.edenresearch.com.
Eden Research's latest filing follows its standard disclosure timetable and provides investors with the latest financial and operational data ahead of the AGM.
